Companies

Perfint to tap PE funds for up to Rs 100 crore

K V Kurmanath Hyderabad | Updated on January 31, 2012 Published on January 31, 2012

To launch tumour ablation platform Maxio

Perfint Healthcare Corporation, the Chennai-based robotic targeting systems for cancer care, will raise Rs 75-100 crore from private equity (PE) funds in the next 18 months in rounds.

The company had already raised Rs 50 crore in two rounds from IDG Ventures, Accel Partners and Norwest Venture Partners in the last four years. It said it has no immediate plans to go public.

“A fresh round of investment would happen immediately. It will be followed by another in 18 months. Those who have invested in us might participate in the subsequent rounds too. We would like to use the proceeds to enter the US and other markets,” Mr Nandakumar, Chief Executive Officer (CEO) and Co- founder of Perfint Healthcare, told Business Line.

The firm set up an Advanced Tech Labs near Boston to work on image guided therapies and high-end complex algorithms. “We are setting up the lab there because we find quality PhDs to probe better medical technologies there,” he said.

Ablation solution

After producing diagnostic equipment, Perfint is expanding to technologies that assist doctors in cancer therapies. “We will be launching Maxio machine system soon. This will help doctors in precision burning of target cells,” he said.

Mr Nandakumar was here to attend the four-day IRIA – 2012 (Indian Radiological and Imaging Association) where the company announced the launch of ROBIO, a robotic targeting system for cancer care and pain care.

The device helps doctors perform CT guided needle procedures to take biopsy samples with a high degree of accuracy in a single attempt. A software solution developed by the firm would help the doctor navigate the needle to the tumour.

“We have sold devices in West Asia, APAC and Russia. We are going to enter the US, European Union, Latin America and Africa,” he said.

kurmanath@thehindu.co.in

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 31, 2012
This article is closed for comments.
Please Email the Editor